MicroRNA: Potential biomarker and target of therapy in acute lung injury

被引:26
作者
Jiang, Z-F [1 ,2 ]
Zhang, L. [1 ,2 ]
Shen, J. [1 ,2 ]
机构
[1] Fudan Univ, Jinshan Hosp, Ctr Emergency, Shanghai 200433, Peoples R China
[2] Fudan Univ, Jinshan Hosp, Intens Care Unit, Med Ctr Chem Injury, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
miRNA; acute lung injury; biomarker; therapy; RESPIRATORY-DISTRESS-SYNDROME; MODULATES MACROPHAGE POLARIZATION; CIRCULATING MICRORNAS; INDUCED INFLAMMATION; MIRNA THERAPEUTICS; PROTECTS MICE; IN-VIVO; KAPPA-B; EXPRESSION; APOPTOSIS;
D O I
10.1177/0960327120926254
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
MicroRNAs (miRNAs) are small noncoding RNAs stretching over 18-22 nucleotides and considered to be modifiers of many respiratory diseases. They are highly evolutionary conserved and have been implicated in several biological processes, including cell proliferation, apoptosis, differentiation, among others. Acute lung injury (ALI) is a fatal disease commonly caused by direct or indirect injury factors and has a high mortality rate in intensive care unit. Changes in expression of several types of miRNAs have been reported in patients with ALI. Some miRNAs suppress cellular injury and accelerate the recovery of ALI by targeting specific molecules and decreasing excessive immune response. For this reason, miRNAs are proposed as potential biomarkers for ALI and as therapeutic targets for this disease. This review summarizes current evidence supporting the role of miRNAs in ALI.
引用
收藏
页码:1429 / 1442
页数:14
相关论文
共 147 条
[1]   Decreased VEGF concentration in lung tissue and vascular injury during ARDS [J].
Abadie, Y ;
Bregeon, F ;
Papazian, L ;
Lange, F ;
Chailley-Heu, B ;
Thomas, P ;
Duvaldestin, P ;
Adnot, S ;
Maitre, B ;
Delclaux, C .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (01) :139-146
[2]   Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake [J].
Abels, Erik R. ;
Breakefield, Xandra O. .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (03) :301-312
[3]   Resveratrol protects mice against SEB-induced acute lung injury and mortality by miR-193a modulation that targets TGF-β signalling [J].
Alghetaa, Hasan ;
Mohammed, Amira ;
Sultan, Muthanna ;
Busbee, Philip ;
Murphy, Angela ;
Chatterjee, Saurabh ;
Nagarkatti, Mitzi ;
Nagarkatti, Prakash .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (05) :2644-2655
[4]   microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[5]   The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome [J].
Antebi, Ben ;
Mohammadipoor, Arezoo ;
Batchinsky, Andriy I. ;
Cancio, Leopoldo C. .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2018, 84 (01) :183-191
[6]  
Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
[7]   miR-122-A key factor and therapeutic target in liver disease [J].
Bandiera, Simonetta ;
Pfeffer, Sebastien ;
Baumert, Thomas F. ;
Zeisel, Mirjam B. .
JOURNAL OF HEPATOLOGY, 2015, 62 (02) :448-457
[8]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[9]   Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries [J].
Bellani, Giacomo ;
Laffey, John G. ;
Pham, Tai ;
Fan, Eddy ;
Brochard, Laurent ;
Esteban, Andres ;
Gattinoni, Luciano ;
van Haren, Frank ;
Larsson, Anders ;
McAuley, Daniel F. ;
Ranieri, Marco ;
Rubenfeld, Gordon ;
Thompson, B. Taylor ;
Wrigge, Hermann ;
Slutsky, Arthur S. ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08) :788-800
[10]   miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart [J].
Bernardo, Bianca C. ;
Ooi, Jenny Y. Y. ;
Lin, Ruby C. Y. ;
McMullen, Julie R. .
FUTURE MEDICINAL CHEMISTRY, 2015, 7 (13) :1771-1792